OnCusp Therapeutics

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments. It is always working to improve the largest value inflection point in the drug development value chain, believing that speeding oncology medication innovation is the most effective method to provide help and hope to cancer patients around the world. It is founded by Bing Yuan, Eric Slosberg, and Andy Fu.

Domain

oncusptx.com

Employees

11-50

Last Funding

$100.0M

Founded

2020

Frequently Asked Questions

What technologies does OnCusp Therapeutics use?+

OnCusp Therapeutics uses 5 technologies including Swiper, Baidu Analytics (百度统计), Cloudflare Browser Insights.

What industry is OnCusp Therapeutics in?+

OnCusp Therapeutics operates in the Biotechnology industry.

Where is OnCusp Therapeutics based?+

OnCusp Therapeutics is headquartered in United States.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026